Jump to content

Scrambler therapy: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
top: added description of application, citation
Line 15: Line 15:
* [[MENS]]
* [[MENS]]
* [[Percutaneous tibial nerve stimulation]]
* [[Percutaneous tibial nerve stimulation]]
* [[Peripheral neuropathy]]


==References==
==References==

Revision as of 04:22, 25 January 2016

Scrambler therapy (sometimes Calmare scrambler therapy or Calmare therapy) involves the use of electronic stimulation on the skin with the goal of overwhelming pain information with non-pain information.[1]

Described in Medscape, in scrambler therapy, "electrocardiographic-like pads are placed around the area of pain. The device then synthesizes different types of nerve action potentials that deliver nonpain information through cutaneous nerves to the pain site."[2]

The technique was invented by Giuseppe Marineo at the University of Rome Tor Vergata.[3] Marineo co-authored and published a research paper, "Scrambler therapy": a new option in neuropathic pain treatment?," in 2000.[4]

Research on the efficacy of scrambler therapy has had mixed results; there is no strong evidence that it is effective in treating neuropathic pain.[5] Although there is some evidence that it may be effective for chemotherapy-induced peripheral neuropathy, further randomized controlled trials are needed to confirm or refute this.[6]

See also

References

  1. ^ Katholi BR, Daghstani SS, Banez GA, Brady KK (2014). "Noninvasive treatments for pediatric complex regional pain syndrome: a focused review". PM&R. 6 (10): 926–33. doi:10.1016/j.pmrj.2014.04.007. PMID 24780851.
  2. ^ Harrison, Pam (11 Jan 2016). "Scrambler Therapy Benefit in Cancer-Related Neuropathic Pain". Medscape (WebMD LLC). Retrieved 24 January 2016.
  3. ^ Anson, Pat (9 April 2014). "Inventor of Calmare Scrambler Tries to Block Sales". National Pain Report.
  4. ^ Serafini, G., Marineo, G. and Sabato, A.F. (2000). "Scrambler therapy": a new option in neuropathic pain treatment?". The Pain Clinic. 12 (4): 287–298. doi:10.1163/156856900750233785.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Rivera, E., & Cianfrocca, M. (2015). "Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer". Cancer Chemotherapy and Pharmacology. 75 (4): 659–670. doi:10.1007/s00280-014-2607-5. PMC 4365177. PMID 25596818.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Pachman, DR; Watson, JC; Loprinzi, CL (December 2014). "Therapeutic strategies for cancer treatment related peripheral neuropathies". Current treatment options in oncology. 15 (4): 567–80. doi:10.1007/s11864-014-0303-7. PMID 25119581.